A cost analysis of Behçet's syndrome in Turkey

Rheumatology

Volumn 46, Issue 4, 2007, Pages 678-682

  Sut, N ^b   Seyahi, E ^a   Yurdakul, S ^a,c   Senocak, M ^b   Yazici, H ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Beh et's syndrome; Cost of illness; Direct costs; Indirect costs

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ABSENTEEISM; ADULT; ARTICLE; BEHCET DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE DURATION; DRUG COST; ECHOGRAPHY; ECONOMIC ASPECT; EYE DISEASE; FEMALE; HEALTH CARE SYSTEM; HEALTH SURVEY; HOSPITAL COST; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT; PRIORITY JOURNAL; QUESTIONNAIRE; SKIN DISEASE; TURKEY (REPUBLIC); VASCULAR DISEASE; COST OF ILLNESS; ECONOMICS; HEALTH CARE COST; HOSPITALIZATION; MEDICAL LEAVE; MIDDLE AGED; RETROSPECTIVE STUDY; SOCIOECONOMICS; STATISTICS;

ADULT; BEHCET SYNDROME; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SICK LEAVE; SOCIOECONOMIC FACTORS; TURKEY;

EID: 34047150863     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel382     Document Type: Article

References (24)

1. Yazici H, Yurdakul S, Hamuryudan V, Fresko I. Behçet's syndrome. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, eds. Rheumatology, 3rd edn. Philadelphia: Mosby, 2003;151:1665-9.
2. Yurdakul S, Gunaydin I, Tuzun Y et al. The prevalence of Behcet's syndrome in a rural area in northern Turkey. J Rheumatol 1988;15:820-2.
3. Idil A, Gurler A, Boyvat A et al. The prevalence of Behcet's disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic Epidemiol 2002;9:325-31.
4. Azizlerli G, Kose AA, Sarica R et al. Prevalence of Behcet's disease in Istanbul, Turkey. Int J Dermatol 2003;42:803-6.
5. Kural-Seyahi E, Fresko I, Seyahi N et al. The long-term mortality and morbidity of Behcet syndrome: A 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine 2003;82:60-76.
6. Hamuryudan V, Yurdakul S, Moral F et al. Pulmonary arterial aneurysms in Behcet's syndrome: A report of 24 cases. Br J Rheumatol 1994;33:48-51.
7. Hamuryudan V, Er T, Seyahi E et al. Pulmonary artery aneurysms in Behcet syndrome. Am J Med 2004;117:867-70.
8. Akman-Demir G, Serdaroglu P, Tasci B. Clinical patterns of neurological involvement in Behcet's disease: Evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 1999;122:2171-82.
9. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. New York: Oxford University Press, 1997.
10. Hunink M, Glasziou P. Decision making in health and medicine. Cambridge: Cambridge University Press, 2001.
11. Berger ML, Bingefors K, Hedblom EC, Pashos CL, Torrance GW. Health care cost, quality and outcomes. International Society for Pharmacoeconomics and Outcomes Research Press, NJ, 2003.
12. Byford S, Torgerson DJ, Raftery J. Cost of illness studies. Br Med J 2000;320:1335-6.
13. Mittendorf T, Merkesdal S, Huelsemann JL, von der Schulenburg JM, Zeidler H, Ruof J. Implementing standardized cost categories within economic evaluations in musculoskeletal diseases. Eur J Health Econ 2003;4:43-9.
14. Merkesdal S, Ruof J, Schoffski O, Bernitt K, Zeidler H, Mau W. Indirect medical costs in early rheumatoid arthritis: Composition of and changes in indirect costs within the first three years of disease. Arthritis Rheum 2001;44:528-34.
15. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990;335:1078-80.
16. http://www.calisma.gov.tr/projeler/tekcati.htm, accessed 1 June 2006.
17. http://www.devletim.com/emeklilik_hizmetleri.asp, accessed 1 June 2006.
18. http://www.tuik.gov.tr/Start.do, accessed 1 September 2006.
19. Celik GE, Bavbek S, Pasaoglu G et al. Direct medical cost of asthma in Ankara, Turkey. Respiration 2004;71:587-93.
20. Zencir M, Kuzu N, Beser NG, Ergin A, Catak B, Sahiner T. Cost of Alzheimer's disease in a developing country setting. Int J Geriatr Psychiatry 2005;20:616-22.
21. Karli N, Zarifoglu M, Ertafs M et al. Economic impact of primary headaches in Turkey: A univerPity hospital based study: part II. J Headache Pain 2006;7:75-82.
22. Erek E, Sever MS, Akoglu E et al. Cost of renal replacement therapy in Turkey. Nephrology 2004;9:33-8.
23. Statistical Yearbook of Turkey 2004, URL: www.die.gov.tr, accessed 1 August 2005.
24. http://siteresources.worldbank.org/DATASTATISTICS/Resources/GNIPC.pdf, accessed 1 June 2006.